NTRBW
Nutriband Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.55
−6.78%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.8M | 2.0M | 2.1M | 2.1M | 2.1M |
| Cost of Revenue | 1.3M | 1.5M | 1.4M | 1.2M | 1.3M |
| Gross Profit | 511.1K | 566.3K | 699.3K | 862.1K | 750.4K |
| Operating Expenses | |||||
| R&D Expense | 1.5M | 1.9M | 3.1M | 2.0M | 982.2K |
| SG&A Expense | 7.2M | 7.0M | 4.3M | 3.8M | 3.9M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 8.7M | 8.9M | 7.4M | 5.7M | 4.9M |
| Cost and Expenses | 10.0M | 10.4M | 8.8M | 7.0M | 6.2M |
| Operating Income (EBIT) | (8.2M) | (8.3M) | (6.7M) | (4.9M) | (4.1M) |
| Non-Operating | |||||
| Interest Income | 22.2K | — | 191.7K | 16.9K | — |
| Interest Expense | 21.7K | 22.5K | 21.4K | 75.8K | 8.3K |
| Net Interest Income | 503.00 | (22.5K) | 170.3K | (59.0K) | (8.3K) |
| Other Non-Op Income/Expense | 76.1K | 88.3K | (3.8M) | (613.4K) | (335.6K) |
| Non-Operating Income (excl Interest) | (97.8K) | (110.9K) | 3.8M | 537.6K | 327.3K |
| EBT (Pre-Tax Income) | (8.1M) | (8.2M) | (10.5M) | (5.5M) | (4.5M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (8.1M) | (8.2M) | (10.5M) | (5.5M) | (4.8M) |
| Earnings from Cont. Ops | (8.1M) | (8.2M) | (10.5M) | (5.5M) | (4.5M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (29.9M) | (30.0M) | (10.5M) | (5.5M) | (4.5M) |
| Per Share | |||||
| Basic EPS | ($2.62) | ($2.58) | ($0.99) | ($0.69) | ($0.57) |
| Diluted EPS | ($2.62) | ($2.58) | ($0.99) | ($0.69) | ($0.57) |
| Revenue Per Share | $0.15 | $0.17 | $0.20 | $0.26 | $0.25 |
| Shares | |||||
| Basic Shares Outstanding | 12.2M | 11.6M | 10.6M | 8.0M | 8.5M |
| Diluted Shares Outstanding | 12.2M | 11.6M | 10.6M | 8.0M | 8.5M |
| Profitability Metrics | |||||
| EBITDA | (7.9M) | (8.0M) | (10.2M) | (5.1M) | (4.1M) |
| D&A | 170.5K | 193.8K | 285.1K | 287.7K | 369.0K |
| EBIT | (8.1M) | (8.2M) | (10.5M) | (5.4M) | (4.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Apr 1, 2026